1.. Introduction
================

1.1.. Biology of Reproduction
-----------------------------

Reproduction is the biological process by which new individual organisms are generated. In sexual reproduction the new organism is a combination of half of the genetic material of the two parents through the fusion of the two gametes: spermatozoon and oocyte \[[@b1-marinedrugs-07-00539]\]. The gametes are formed during specific processes such as oogenesis and spermatogenesis, both characterized by a unique process of cell division occurring only in gametes, called meiosis, whose goal is the production of highly specialized haploid cells for fertilisation. During gametogenesis the two gametes respectively in the ovary and the testis undergo maturation whereas gametes are activated at fertilisation. Oocyte maturation is the last phase of oogenesis during which the oocyte acquires the competence to be ovulated and fertilised. In the majority of the species, the oocyte arrests at different stages of meiotic division, in particular the block occurring in the first meiotic prophase marks the state of immature oocyte characterized by a prominent nucleus called germinal vesicle (GV). Meiosis is resumed in response to a stimulus that is different among the species and meiosis progression occurs with the germinal vesicle breakdown (GVBD). Then it progresses until a second arrest at metaphase I (MI) or II (MII) that is removed after successful fertilisation.

***Oocyte maturation*** is usually defined as the period of progression from the first to the second meiotic arrest and involves coordinated nuclear and cytoplasmic modifications \[[@b2-marinedrugs-07-00539]\]. If nuclear maturation is underlied by the meiotic process, cytoplasmic maturation is a more obscure process and involves both morphological and functional alterations related to: (i) changes in the expression profile of cell cycle control proteins responsible for driving the oocyte towards developmental competencies \[[@b3-marinedrugs-07-00539]--[@b7-marinedrugs-07-00539]\]; (ii) relocation of mitochondria and endoplasmic reticulum \[[@b8-marinedrugs-07-00539]--[@b10-marinedrugs-07-00539]\]; (iii) transcriptional modifications of mRNA \[[@b11-marinedrugs-07-00539]\]; (iv) modification of the plasma membrane permeability \[[@b12-marinedrugs-07-00539]--[@b15-marinedrugs-07-00539]\]; (v) differentiation of the calcium signalling machinery \[[@b16-marinedrugs-07-00539]\].

The control of oocyte maturation involves a complex interplay between oocyte and the extra cellular membranes and the environment, with the participation of numerous metabolic pathways. The resumption of meiotic maturation relies on two different mechanisms that are stimulation by chemical/hormonal substances and the removal of an inhibitory signal. The former involves the production of a ligand that acts on the oocyte at the GV stage inducing the GVBD.

Meiosis arrest and resumption are modulated by numerous messengers. Many studies have provided evidence of the involvement of cyclic nucleotides in the maintenance of meiotic arrest \[[@b17-marinedrugs-07-00539]\]. In particular, high levels of cyclic adenosine mono-phosphate (cAMP), some analogues, cAMP-dependent protein kinase (PKA) and related substances such as GPR3, act by preventing spontaneous maturation and/or blocking GVBD *in vitro* or, on the contrary, may release oocyte from meiotic arrest \[[@b18-marinedrugs-07-00539],[@b19-marinedrugs-07-00539]\].

Another important factor responsible for meiotic resumption is the M-phase promoting factor (MPF) showed for the first time in amphibian oocytes in the '70s, by Masui \[[@b20-marinedrugs-07-00539]\]. Although most of the work on MPF has been carried out with frog and starfish oocytes, accumulated evidence demonstrates that this mechanism exists in other animal models, such as mammals and invertebrates \[[@b12-marinedrugs-07-00539],[@b16-marinedrugs-07-00539],[@b21-marinedrugs-07-00539]--[@b23-marinedrugs-07-00539]\].

There is a general consensus that calcium ions play a fundamental role in the resumption of meiotic maturation \[[@b4-marinedrugs-07-00539],[@b16-marinedrugs-07-00539],[@b24-marinedrugs-07-00539],[@b25-marinedrugs-07-00539]\] in different species. The external calcium is involved in meiotic resumption in ascidian oocytes \[[@b15-marinedrugs-07-00539]\]. In mouse, calcium oscillations precede GVBD \[[@b26-marinedrugs-07-00539]\] that is delayed by removing of external calcium \[[@b27-marinedrugs-07-00539]\].

As showed in mammalian oocytes, meiotic maturation is a complex process that involves extensive rearrangement of microtubules and actin filaments \[[@b28-marinedrugs-07-00539]\]. Depending on the species, actin filaments control chromatin movement during oocyte development and regulation of organelle positioning; they also participate in oocyte cortex formation and in polarity establishment. The actin filaments, furthermore, play several roles in cortical granule movement, anchoring and exocytosis, and, together with myosin, are also involved in polar body emission \[[@b29-marinedrugs-07-00539]\].

***Sperm maturation*** is defined as the development of the ability of spermatozoa to fertilise eggs. In this process, the sperm undergoes morphological, biochemical, and physiological modifications initially in the testis (testicular maturation) and later in the epididymis (epididymal maturation). In the former, maturation occurs at molecular levels especially during the last phase of spermatogenesis known as spermiogenesis; here, the large round haploid spermatide undergoes a dramatic morphological and molecular changes including: replacement of histones with protamines, high condensation of chromatin, formation of the acrosome, centrioles migration and tail assemblage. In the mean time, sperm acquires a functional competence, *e.g.*, acquisition of flagellar beating providing forward propulsion and compactness of nuclear and flagellar structures.

After that, in mammals, sperm function required for fertilisation seems to be developed in the epididymis, whereas in marine animals it takes place at the moment of its spawning in the environment \[[@b1-marinedrugs-07-00539],[@b30-marinedrugs-07-00539]\]. In marine organisms, spawning, i.e. the release of sperm and often eggs into the environment, is a common mechanism of reproduction \[[@b31-marinedrugs-07-00539]\]. The probability of successful fertilization in this mating strategy depends on many factors, including the number and the distribution of spawners \[[@b32-marinedrugs-07-00539]\], the timing of gamete release \[[@b33-marinedrugs-07-00539]\], the ways in which released gametes are dispersed \[[@b34-marinedrugs-07-00539]\] and finally properties of gametes themselves \[[@b35-marinedrugs-07-00539]\].

***Fertilisation*** is a highly specialized process of cell to cell interaction that involves many steps such as recognition of complementary receptors on the surface of the two gametes, their binding, and the fusion of the two plasma membranes \[[@b1-marinedrugs-07-00539],[@b36-marinedrugs-07-00539]\]. During this complex process each gamete activates its partner. First, the spermatozoon responds to signal originating from the oocyte and its investments by rapidly changing its behaviour, form and function. Multi-step events of sperm activation involve motility, chemotaxis, first binding, acrosome reaction, second binding and fusion \[[@b1-marinedrugs-07-00539],[@b30-marinedrugs-07-00539],[@b37-marinedrugs-07-00539]\]. All these steps are mediated by known molecules. In particular, the acrosome reaction is an essential requirement to render the sperm plasma membrane highly fusible. The acrosome is an organelle located on the tip of the sperm head and due to the contact between ligand and receptors on the two gametes membranes undergoes the exocytosis \[[@b38-marinedrugs-07-00539]\]. This process that is calcium-mediated allows the spermatozoon to cross the zona pellucida that surrounds the oocyte and to take contact with the oocyte plasma membrane, after that fusion of the gametes occurs \[[@b29-marinedrugs-07-00539]\]. Following fusion, the spermatozoon triggers the quiescent oocyte into metabolic activation inducing electrical, morphological and metabolic modifications.

Electrical changes of the oocyte plasma membrane are a crucial event of the oocyte activation \[[@b40-marinedrugs-07-00539]\]. First indications on the role of ion currents at fertilisation were provided in marine animals in the early '80. In the echinoderm oocytes the occurrence of a depolarizing fertilisation potential was attributed to the activation of a transient voltage-dependent inward current \[[@b41-marinedrugs-07-00539],[@b42-marinedrugs-07-00539]\]. Subsequently, it was possible to determine that the ion fluxes responsible for fertilisation potential crossed the plasma membrane as a ion current named fertilisation current \[[@b43-marinedrugs-07-00539]\]. Biophysical studies characterized the channels responsible for the fertilisation current as large non-specific and highly conductive ion channels \[[@b43-marinedrugs-07-00539],[@b44-marinedrugs-07-00539]\] and subsequently to mainly mediated by sodium currents \[[@b14-marinedrugs-07-00539]\]. In marine worm eggs, the fertilisation potential can be thought of as a sum of a Na^+^-dependent "sperm receptor potential" and a superimposed Ca^2+^-dependent action potential \[[@b45-marinedrugs-07-00539]\].

Resting potential changes and fertilisation currents has been recorded in many vertebrate oocytes such as amphibians \[[@b46-marinedrugs-07-00539]\], hamster \[[@b47-marinedrugs-07-00539]\], rabbit \[[@b48-marinedrugs-07-00539]\], mouse \[[@b49-marinedrugs-07-00539]\], human \[[@b50-marinedrugs-07-00539]\] and bovine \[[@b51-marinedrugs-07-00539]\]. In addition, it has been shown that electrical modifications is a mechanism for preventing polyspermy in sea urchin \[[@b52-marinedrugs-07-00539]\], marine worm \[[@b53-marinedrugs-07-00539]\], ascidian \[[@b54-marinedrugs-07-00539]\] and Xenopus \[[@b46-marinedrugs-07-00539]\] oocytes.

Morphological modifications are mainly due to the triggering of the cortical reaction \[[@b9-marinedrugs-07-00539]\] or to the contraction of the oocyte body due to a calcium wave that crosses it from pole to pole \[[@b55-marinedrugs-07-00539]\].

Finally, numerous metabolic modifications occur such as modulation of phosphoinositide pathway \[[@b5-marinedrugs-07-00539]--[@b59-marinedrugs-07-00539]\] with inositol trisphosphate (IP~3~) formation. The latter gives rise to a fundamental event in oocyte activation \[[@b25-marinedrugs-07-00539]\] that is the release of intracellular calcium. This calcium signal is responsible for the exocytosis of cortical granules, resumption of meiosis and activation of development \[[@b60-marinedrugs-07-00539]--[@b65-marinedrugs-07-00539]\].

A calcium increase may occur in oocytes as single increase, as in amphibians \[[@b66-marinedrugs-07-00539]\] and sea urchins \[[@b67-marinedrugs-07-00539]\] or in the form of repetitive oscillations as in ascidians \[[@b68-marinedrugs-07-00539]\] and mammals \[[@b69-marinedrugs-07-00539]--[@b73-marinedrugs-07-00539]\].

In many species, fusion between sperm and the oocyte occurs at the tip of microvilli, and the actin filaments in the microvilli may participate in sperm-egg binding and fusion. As described above, the ion currents play a crucial role in the gamete activation and embryo development, so many fertilisation blockers are drugs affecting physiological modifications of cytoskeleton and/or ion currents.

In conclusion, a correct maturation and reciprocal activation of gametes are a pre-requisite for successful fertilisation and although their temporal and spatial sequences are not yet fully clarified, they involve numerous molecules in form of ligand-substrate complexes, ion current changes, and intracellular messenger pathway mobilization \[[@b24-marinedrugs-07-00539],[@b74-marinedrugs-07-00539],[@b75-marinedrugs-07-00539]\].

The basic mechanism of fertilisation has been widely debated, at present there are two main hypotheses as to how the spermatozoon triggers the oocyte into activation \[[@b24-marinedrugs-07-00539]\]. The first points on the binding of the spermatozoon to an oocyte membrane receptor whose signal is in turn transduced by a G-protein mechanism. The contrasting idea suggests that the spermatozoon contains a soluble factor that is released into the oocyte cytoplasm following the gamete fusion \[[@b76-marinedrugs-07-00539],[@b77-marinedrugs-07-00539]\]. Both the mechanisms have been supported by experimental evidence, however in the last decade accumulating evidence indicate that the sperm factor hypothesis is more feasible. Other potential candidates were proposed by Parrington \[[@b78-marinedrugs-07-00539]\] to be a 33 KDa molecular mass protein and/or a truncated form of the c-kit tyrosine kinase receptor \[[@b79-marinedrugs-07-00539]\]. At present it has been well documented that the phospholipase Czeta is soluble factor in mammals. However, many investigators are still working to clarify the molecular nature of sperm factor in invetebrates \[[@b80-marinedrugs-07-00539],[@b81-marinedrugs-07-00539]\].

***Embryo development.*** Successful fertilisation drives the oocyte into meiosis completion and exit and the formation of the zygote. This represents the first diploid cell of a new organism that divides by mitosis into a number of smaller cells named blastomeres. This process is the cleavage and is different depending on the species. Early cleavages are often synchronous, but when synchronism is lost, the blastomeres become arranged in layers or groups that mark their specific differences resulting from an unequal distribution of cytoplasmic components and/or from induction from neighboring cells. The blastomere nuclei are in fact subjected to a cytoplasmic environment that in turn affects gene activity. This triggers the programme of development that gives rise to the cell lines, e.g. the future embryo tissue (nerve, muscle, epidermis etc.). Transition from maternal gene products to the new individuals gene products takes place at different stages of division depending on the species. The first steps of embryogenesis share common characteristics among species (blastulation, gastrulation, neurulation), however the late events leading to formation of the new individual is totally different, e.g. the formation of swimming larvae and metamorphosis occurring in sea water in marine animals *vs* embryo implantation in mammals occurring *in utero*.

Although a large volume of literature deals with developmental biology, this is a very complex step-by step process that is difficult to summarize \[[@b82-marinedrugs-07-00539],[@b83-marinedrugs-07-00539]\].

1.2.. Marine Drugs
------------------

Before describing the action of marine drugs on reproductive mechanisms it is worth to mentioning that most, if not all, marine invertebrates harbour microorganisms that include bacteria, cyanobacteria and fungi within their tissues extra-and intracellular space \[[@b84-marinedrugs-07-00539],[@b85-marinedrugs-07-00539]\]. The relationship between marine invertebrates and marine microorganisms that may serve as food or that live either permanently or temporarily inside of marine macroorganisms are highly complex and far from being well understood \[[@b85-marinedrugs-07-00539]--[@b87-marinedrugs-07-00539]\]. Microorganisms not only serve as food for filter feeders or (in the case of cyanobacteria and chemoautotrophic bacteria) enrich the diet of their hosts by carbon and nitrogen fixation, but may perhaps also be involved in the biosynthesis of natural products \[[@b88-marinedrugs-07-00539]\]. So, it is clear that there is often a difficulty in clarifying the real producer of a marine compound.

In this review, we have classified marine natural products in two groups: i) compounds with known and tested impact on reproduction processes; ii) compounds with plausible impact on reproductive processes, chosen on the basis of their molecular mechanisms or targets. For convenience, we describe the origin of the drugs on the basis of the zoological scale order.

### 1.2.1.. Marine Natural Products Affecting Reproduction

A limited number of studies have suggested that some of these compounds may have ecological roles as allelochemicals, specifically including compounds that may inhibit competing species. These allelochemicals may also play a role in defense against potential predators and grazers, particularly aquatic invertebrates and their larvae \[[@b89-marinedrugs-07-00539]\].

In the endless fight between predator and prey, the latter does not play the role of passive victim. Beyond direct defense, characterized by a series of mechanisms to avoid being killed, prey have also developed indirect long-term defenses, a sort of preventive war against predators: in fact, by producing antiproliferative compounds many organisms are able to regulate the population dynamics of their marine predators, in particular, interfering with some crucial processes of their reproductive cycle, such as: maturation, fertilisation, and early embryo development.

Cyanobacteria are Gram-negative bacteria capable of producing a wide range of potent toxins as secondary metabolites, i. e. the cyanotoxins, whose action is still rather unknown \[[@b90-marinedrugs-07-00539],[@b91-marinedrugs-07-00539]\]. On the contrary, other bacteria produce widely known marine neurotoxins; **tetrodotoxin** (TTX) is one of these; it is a voltage-gated sodium current blocker and a major toxic component contained in pufferfish of the Family Tetraodontidae. Animals containing TTX are not limited to certain species of puffer. A wide variety of marine and terrestrial animals are now known to have TTX, including, but not limited to, pufferfish, salamanders, frogs, horseshoe crabs, xanthid crabs, blue-ringed octopus, and starfish \[[@b92-marinedrugs-07-00539]\]. In the pufferfish, TTX is concentrated in the ovary and liver, but other organs including skin, intestine, and muscle contain TTX in some species of puffer. The reason for such a wide distribution is that TTX is not produced by the puffer fish, but is produced by certain species of bacteria including *Vibrio* sp. and comes to be in the animals through the food chain \[[@b93-marinedrugs-07-00539]--[@b96-marinedrugs-07-00539]\]. As demonstrated in the ascidian *Ciona intestinalis*, inhibition of sodium currents at the time of fertilisation current generation gave rise to a high percentage of anomalous embryos, in which the spatial orientation at the 8/16-cell stage is lost \[[@b14-marinedrugs-07-00539]\].

The difficulty in identifying the real producer is clear also for another drug, **maitotoxin** (MTX), which is an extremely potent toxin obtained from the marine dinoflagellate *Gambierdiscus toxicus* and involved in ciguatera poisoning. MTX was previously detected in the viscera of maito (a small herbivorous fish, *Ctenochaetus striatus*, called "maito" in Tahiti), but further studies \[[@b97-marinedrugs-07-00539],[@b98-marinedrugs-07-00539]\] found a good correlation between dinoflagellates in the gut contents and the toxicity of the viscera. The dinoflagellate turned out to represent both a new genus and new species, and it was named *Gambierdiscus toxicus* \[[@b99-marinedrugs-07-00539]\]. This toxin is a powerful activator of changes in the intracellular calcium concentration and it induces a potassium release from the oocytes simultaneously with a sodium entry into unfertilised eggs, although experimental evidence suggests that MTX has no ionophoretic activity *per se* \[[@b100-marinedrugs-07-00539]--[@b103-marinedrugs-07-00539]\]. MTX inhibits sea urchin egg fertilisation in a dose-dependent manner but, maybe, ion transport perturbations are probably not the direct cause of fertilisation inhibition which could be related to a modification of the plasma membrane of the female gametes by this hydrophilic toxin \[[@b101-marinedrugs-07-00539]\]. A different effect has been found in mouse, where the results suggest that putative channels activated by MTX may be involved in the calcium influx required for mouse sperm acrosome reaction \[[@b103-marinedrugs-07-00539]\].

Many marine drugs represent a useful tool for studying cellular processes: one of the most famous is **okadaic acid** (OA): the latter acts as a potent inhibitor of protein phosphatases \[[@b104-marinedrugs-07-00539]\] and has turned out to be a valuable tool for the study of phosphorylation based processes of cellular signaling \[[@b105-marinedrugs-07-00539]\]. The protein serine/threonine phosphatases are a unique family of enzymes that catalyze the specific dephosphorylation of phosphoserine or phosphothreonine residues in many cell types. The potent activity of OA is remarkably conserved across phyla: this toxin inhibits phosphatase activity in mammals, yeast, and higher plants \[[@b106-marinedrugs-07-00539]\]. OA was initially isolated and characterized from the sponges *Halichondria okadai* and *H. melanodocia* \[[@b107-marinedrugs-07-00539]\]. However, it was later shown to be produced by dinoflagellates of the genera *Prorocentrum* and *Dinophysis* \[[@b104-marinedrugs-07-00539],[@b108-marinedrugs-07-00539]--[@b110-marinedrugs-07-00539]\] and is now considered to be of dietary origin rather than a "true" sponge metabolite in terms of its biosynthetic origin. The function of OA in sponges is not well understood. Studies by Wiens *et al.* \[[@b111-marinedrugs-07-00539]\] have provided evidence for at least two putative roles of OA within the sponge *Suberites domuncula*. At low concentrations, OA triggers a MAP kinase p38-regulated defense system against bacteria. At elevated concentrations, OA acts as an apoptogen and promotes expression of the proapoptotic caspase gene with a simultaneous down-regulation of the expression of the anti-apoptotic Bcl-2 homolog gene. In subsequent studies of *S. domuncula*, Schroder *et al.* \[[@b112-marinedrugs-07-00539]\] suggested that OA may serve as a defense molecule by inducing apoptosis in symbiotic or parasitic annelids. \[[@b113-marinedrugs-07-00539]\]. As protein phosphatase specific inhibitor, OA has previously been used to stimulate chromatin condensation and premature germinal vesicle breakdown in invertebrate and vertebrate oocytes \[[@b114-marinedrugs-07-00539]--[@b123-marinedrugs-07-00539]\].

Like TTX, **brevetoxins** are also voltage-gated sodium channel inhibitors, but these marine toxins are produced by the dinoflagellate *Karenia brevis*. Kimm-Brinson and Ramsdell \[[@b124-marinedrugs-07-00539]\] suggested that the larvae of medaka fish (*Oryzias latipes*), but not the eggs, are susceptible to *Karenia brevis*. In contrast, an earlier study with the sea urchin (*Lytechinus variegatus*) reported that lysates of *K. brevis* administered to eggs did induce developmental abnormalities \[[@b125-marinedrugs-07-00539]\]. This study found that sperm motility, egg fertilisation, and development through the blastula stage were unaffected; however, mortality and developmental abnormalities occurred in about 50% in embryos at gastrula stage and 80% in embryos at pluteus stage. The reason for the difference between the study with the red drum eggs and the sea urchin eggs may result from the use of *K. brevis* cells and lysates. The persistence of red tides from the late autumn until early spring has suggested that the spawning of some marine species may be subject to the adverse effect of red tide toxins. Steidinger *et al.* \[[@b126-marinedrugs-07-00539]\] also emphasized the need for attention to the effects of red tide outbreaks on migratory species, as many species seek estuaries for breeding and nursery grounds. Based on studies with other classes of fat-soluble contaminants, somatic stores of toxin in fish are transferred during oogenesis and lead to larval toxicity \[[@b127-marinedrugs-07-00539]\].

*K. brevis* red tides have been associated with mortality events of many aquatic animals including finfish, sea turtles, and sea birds during their adult stages \[[@b126-marinedrugs-07-00539],[@b128-marinedrugs-07-00539]--[@b135-marinedrugs-07-00539]\]. These animals have been known to bioaccumulate substantial body burdens of contaminants at times, and in certain cases transfer toxicity to offspring during oogenesis. Given the similarity of developmental processes found between higher and lower vertebrates, teratogenic effects of brevetoxins have the potential to occur among different phylogenetic classes \[[@b124-marinedrugs-07-00539]\].

The last 2 decades have seen much controversy concerning the negative impacts that consumption of diatoms may have upon copepods. Despite some contrasting data \[[@b136-marinedrugs-07-00539]\], diatom-derived aldehydes have been shown to interfere with reproductive mechanism in copepods \[[@b137-marinedrugs-07-00539]--[@b139-marinedrugs-07-00539]\] and polychaetes and echinoderms \[[@b140-marinedrugs-07-00539],[@b141-marinedrugs-07-00539]\]. In the ascidian *Ciona intestinalis*, **2-*trans*-4-*trans*-decadienal** (DD) and **2-*trans*-4-*cis*-7-*cis*-decatrienal** (DT) inhibit the fertilisation current ([Figure 1](#f1-marinedrugs-07-00539){ref-type="fig"}) which is generated in oocyte upon interaction with the spermatozoon. In particular, DD may have a dual effect on reproductive processes, influencing primary fertilisation events such as gating of fertilisation channels and secondary processes such as actin reorganization which is responsible for the segregation of cell lineages. In the same study, DD altered actin filaments and mitocondrial migration after contraction, leading to a disturbance in cleavage formation ([Figure 2A](#f2-marinedrugs-07-00539){ref-type="fig"}). However, DD also induced larval teratogeny at low concentrations ([Figure 2B](#f2-marinedrugs-07-00539){ref-type="fig"}), possibly due to actin perturbation \[[@b142-marinedrugs-07-00539]\].

**Domoic acid** (DA) is produced by red alga *Chondria armata* and planktonic diatoms of the genus *Pseudo-nitzschia*, \[[@b143-marinedrugs-07-00539]\]. Over the last decade, reproductive failure in California sea lions has been increasingly associated with harmful algal blooms, most notably DA produced by *Pseudo-nitzschia* spp. \[[@b144-marinedrugs-07-00539]--[@b146-marinedrugs-07-00539]\]. The food web plays the primary role in the transmission of DA from *Pseudo-nitzschia* blooms to the California sea lion \[[@b144-marinedrugs-07-00539],[@b147-marinedrugs-07-00539]\]. Common vectors are pelagic planktivorous fish, which accumulate DA-containing diatoms in their gut exceeding toxin concentrations of one part per thousand, exceptionally high levels for a natural toxin \[[@b147-marinedrugs-07-00539],[@b148-marinedrugs-07-00539]\]. Additionally, *Pseudo-nitzschia*, which form long chains of cells, will sink to the ocean floor where the DA effectively infiltrates the benthic food web and provides an additional source of vectoring \[[@b149-marinedrugs-07-00539]\]. At the level of the receptor in the brain, DA binds to kainate subtypes of ionotropic glutamate receptors to induce excitotoxicity by release of glutamate and activation of *N-*methyl-[d]{.smallcaps}-aspartate ionotropic glutamate receptors \[[@b150-marinedrugs-07-00539]\]. DA crosses the placenta, readily enters the neonatal brain and is retained in the amniotic fluid \[[@b151-marinedrugs-07-00539]\]. The early fetal brain is electrically silent, but expresses levels of ionotropic glutamate receptors that guide the migration of neurons to the appropriate brain regions and facilitate in the formation correct synapses. DA, which is normally cleared rapidly by renal filtration in adult animals, is more toxic to animals *in utero* because of a longer residence time in the fetal-maternal unit and greater access to the fetal brain \[[@b143-marinedrugs-07-00539]\].

The effect of DA in invertebrates is also known. As a result of the DA exposure, larval growth of king scallop, *Pecten maximus*, measured in terms of shell length and the appearance of the eye-spot, and larval survival were significantly compromised. The negative effect of DA exposure suggests that this toxin could possibly influence natural recruitment in *P. maximus*, and it may be necessary to protect hatchery-cultured scallop larvae from DA during toxic *Pseudo-nitzschia* blooms \[[@b152-marinedrugs-07-00539]\].

Embryo development is blocked by several drugs isolated from algae: **caulerpenyne** does not affect the microfilament-dependent processes of fertilisation and cytokinesis and allows the beginning of mitosis, but prevents normal DNA replication and results in metaphase-like arrest of sea urchin embryos \[[@b153-marinedrugs-07-00539]\]; **stypoldione** uncouples cytokinesis from mitosis at the lowest effective concentrations and, although it can disrupt microtubules at relatively higher concentrations, it inhibits cell division at the lowest effective concentrations by a selective action on cytokinesis through a mechanism that does not appear to involve disassembly of microtubules \[[@b154-marinedrugs-07-00539]\].

Sometimes it happens that the same compound may have several contrasting applications: for example, a sulfono glycolipid (**S-ACT-1**) isolated from *Gelidiella acerosa*, a Sri Lankan marine red alga, has a potent human sperm motility stimulating activity *in vitro* and has the potential to be developed into a sperm stimulant \[[@b155-marinedrugs-07-00539]\], but crude extracts from the same species showed elevated post-implantation loss. Since post-coital contraceptive activity of another red alga, *Gracilaria corticata,* was due to enhanced pre-implantation loss, marine red algae could represent a useful source to be harvested for potential post-coital contraceptive drugs \[[@b156-marinedrugs-07-00539]\].

Williamson *et al*. \[[@b157-marinedrugs-07-00539]\] compared the effects of chemical cues from host algae on different life history stages of the sea urchin *Holopneustes purpurascens*. In sublittoral habitats, *H. purpurascens* occurred primarily on two algal hosts: red alga (*Delisea pulchra*) and kelp (*Ecklonia radiata*). Sea urchin larvae rapidly metamorphosed in the presence of *D. pulchra*, but metamorphosis was delayed or absent in the presence of *E. radiata. D. pulchra* produces a polar chemical inducer of metamorphosis not found in *E. radiata*. In contrast to larval metamorphosis, feeding and performance of juvenile and adult sea urchins were considerably worse on *D. pulchra* than on *E. radiata*.

To our knowledge, there are just few marine drugs that affect gamete maturation by interacting with the cytoskeleton \[[@b158-marinedrugs-07-00539]--[@b160-marinedrugs-07-00539]\]: among them, **jasplakinolide**, a marine compound from sponges, was found to arrest oocytes *in vitro* maturation acting as a microfilament inhibitor, this also affects fertilisation in mice \[[@b161-marinedrugs-07-00539],[@b162-marinedrugs-07-00539]\]; **theonellapeptolide Ie**, from *Petrosa* species, induced malformed maturation through disturbance of cortical F-actin distribution \[[@b158-marinedrugs-07-00539]\]; also **strongylophorines**, isolated from *Strongylophora strongylata*, inhibited the maturation of starfish oocytes by affecting actin \[[@b160-marinedrugs-07-00539]\].

Other marine toxins, the **latrunculins**, produced by certain sponges, including genus *Latrunculia*, inhibit the microfilament-mediated processes during fertilisation, cleavage and early development in sea urchins and mice \[[@b163-marinedrugs-07-00539]\], even more potent than the cytochalasins \[[@b164-marinedrugs-07-00539]\].

However, not all the compounds from the sponge have the same target: for example, **(−)-10-epi-axisonitrile-3**, a spirocyclic sesquiterpene isocyanide obtained from the marine sponge *Geodia exigua*, immobilized sperm of sea urchin and starfish and in turn block fertilisation, by inhibiting the phosphocreatine shuttle participating in the high-energy phosphate metabolism \[[@b165-marinedrugs-07-00539]\]; **theonellapeptolide IId**, isolated from *Theonella swinhoei*, prevented fertilisation of sea urchin while has no effect on early embryonic development of fertilised eggs \[[@b166-marinedrugs-07-00539]\]; also **jaspisin**, isolated from the extract of a marine sponge, *Jaspis* species, has different properties: it is a selective inhibitor of exoplasmic membrane fusion in echinoderms, blocking fusion between the sperm acrosomal process and the egg plasma membrane, and also embryo hatching \[[@b167-marinedrugs-07-00539]--[@b169-marinedrugs-07-00539]\]. Similarly to jaspisin, but differently from 10-epi-Axisonitrile-3**,** there are other inhibitors of echinoderm fertilisation isolated from sponge, **callyspongins A and B** \[[@b170-marinedrugs-07-00539]\] and **halenaquinol sulfate** \[[@b171-marinedrugs-07-00539],[@b172-marinedrugs-07-00539]\], that are able to inhibit sperm-egg fusion without affecting sperm motility \[[@b165-marinedrugs-07-00539]\]. **Calyculin-A**, originally derived from the marine sponge *Discodermia calyx*, is similar to okadaic acid in its potent inhibition of protein phosphatases and thus in its impact on reproduction \[[@b173-marinedrugs-07-00539],[@b174-marinedrugs-07-00539]\].

Bacteria, algae and sponges are not the only source of marine products: Agius *et al.* \[[@b175-marinedrugs-07-00539]\] demonstrated that under illumination **bonellin,** a compound isolated from *Bonellia viridis* \[[@b176-marinedrugs-07-00539]\], causes depression of oxygen uptake by spermatozoa and developmental arrest of echinoid and Bonellia eggs. The effect on the eggs may primarily be due to the crosslinking of membrane proteins and to the formation of peroxydase that results in the cytolysis of the unfertilised eggs and in the inhibition of cleavage \[[@b177-marinedrugs-07-00539]\]. Bonellin is able to arrest the motility of swimming larvae of *C. intestinalis*, but, since the fibrillar structures appear to be unaltered, also this impact seems a consequence of membrane modifications \[[@b178-marinedrugs-07-00539]\].

Recently, spermicidal activity has been found in sea cucumber *Bohadschia vitiensis* whole-body extracts followed by isolation and characterization of bioactive molecule, **bivittoside D**, able to induce human sperm membrane permeabilization \[[@b179-marinedrugs-07-00539]\].

Even some early chordates are supposed to be a promising source for marine drugs affecting reproduction processes: **methoxyconidiol**, extracted from the ascidian *Aplidium aff. densum* \[[@b180-marinedrugs-07-00539]\], inhibits the cleavage of sea urchin *Sphaerechinus granularis* and *Paracentrotus lividus* fertilised eggs: infact, it disrupts M-phase progression and completely blocks cytokinesis without having any effect on DNA replication, most likely by affecting microtubule dynamics \[[@b181-marinedrugs-07-00539]\]. In [Table 1](#t1-marinedrugs-07-00539){ref-type="table"}, we provide a summary of the significant data described above.

### 1.2.2.. Potential Impact of Marine Drugs

As described above, reproduction is a complex process characterized by many crucial steps. It is clear that every marine compound able to affect in some way one of these events could affect reproduction either in natural setting and *in vitro*. A good example to better understand the huge potential of marine organisms as drug source is given by marine sponges. The latter have been considered to be a gold mine during the past 50 years, with respect to the diversity of their secondary metabolites \[[@b182-marinedrugs-07-00539]\]. A huge amount of marine products has been described \[[@b183-marinedrugs-07-00539]--[@b187-marinedrugs-07-00539]\] and sponges, in particular, are the source of more than 5,300 different products. Every year hundreds of new compounds are being discovered \[[@b184-marinedrugs-07-00539]--[@b186-marinedrugs-07-00539]\], leading to identification of novel therapeutic agents showing a broad spectrum of pharmacological activity; therefore, more marine natural products will probably become potential leads for clinical development as novel therapeutic agents for the treatment of multiple disease categories \[[@b188-marinedrugs-07-00539]--[@b190-marinedrugs-07-00539]\].

Marine compounds showed different effects on many molecules that are in different ways involved in reproduction, for example, they inhibit protein kinase C \[[@b113-marinedrugs-07-00539],[@b191-marinedrugs-07-00539]--[@b193-marinedrugs-07-00539]\], calcium \[[@b194-marinedrugs-07-00539]--[@b196-marinedrugs-07-00539]\], sodium \[[@b197-marinedrugs-07-00539]--[@b201-marinedrugs-07-00539]\] and potassium channels \[[@b202-marinedrugs-07-00539]--[@b206-marinedrugs-07-00539]\]. Similarly, other targets are IP~3~ receptors, endoplasmic reticulum calcium pumps \[[@b207-marinedrugs-07-00539]\], microtubules \[[@b208-marinedrugs-07-00539]--[@b216-marinedrugs-07-00539]\]; microfilaments \[[@b217-marinedrugs-07-00539]--[@b221-marinedrugs-07-00539]\]; and plasma membrane \[[@b222-marinedrugs-07-00539],[@b223-marinedrugs-07-00539]\].

Even though this is not proved yet, we may hypothesize their plausible impact on reproduction on the basis of their molecular targets, either *in vivo* and *in vitro*. Over the last few decades significant efforts have been made, by both pharmaceutical companies and academic institutions, to isolate and identify new marine-derived natural products. Because of the diversity in ocean life many new potentially interesting compounds are continuously being discovered.

Despite the risks associated with marine toxins, such as food poisoning or harmful algal blooms, these biogenic compounds have proven their advantage and potential in several fields, particularly as new therapeutic agents for a variety of diseases: in fact, marine ecosystem is an enormously rich source of natural products with promising therapeutic usefulness in oncology, providing anticancer agents with novel mechanisms of action \[[@b224-marinedrugs-07-00539]--227\].

This review reports current understanding of the impacts of compounds from marine organisms on the main reproductive processes and some of their specific mechanisms underlying gametogenesis, fertilisation and very early embryo development. Although most of the data provide evidence that such compounds adversely affect reproductive success, marine drugs may represent a wide source with potential application in improving reproductive fitness.
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![Effect of diatom-derived aldheyde 2-trans-4-trans-decadienal (DD) on fertilisation currents recorded in the whole-cell voltage clamp configuration in *Ciona intestinalis* oocytes. a: normal fertilisation current; b: oocytes incubated in acetaldehyde and then fertilised showed a normal fertilisation current similar to the control; c: oocytes incubated in the diatom aldehyde DD (1.5 μg/mL) and then fertilised showed 50% reduction in fertilisation current amplitude; d: oocytes incubated in more concentrated DD (2 μg/mL) and then fertilised showed complete inhibition of the fertilisation current. Modified from Tosti *et al.* \[[@b142-marinedrugs-07-00539]\].](marinedrugs-07-00539f1){#f1-marinedrugs-07-00539}

![**A**: Percentage reduction of first cleavage of *Ciona intestinalis* oocytes incubated 10 minutes at different concentrations of DD and then fertilised. **B**: Percentage of embryos that reached the larval stage when exposed to different concentrations of DD. Dark shading shows the percentage of abnormal larvae. Light shading shows the percentage of normal larvae. Insert: top panel shows a normally developed *C. intestinalis* larva 24 hours after fertilisation. Bottom panel: various degrees of malformations such as stunted and elongated tail, lack of sensory organ pigmentation, blockage at the 118-cell stage (gastrula). From Tosti *et al.* \[[@b142-marinedrugs-07-00539]\].](marinedrugs-07-00539f2){#f2-marinedrugs-07-00539}

###### 

Summary of significant data reported in the text.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Drug**                         **Source**                                                  **Target - Impact**                                                                                                              **References**
  -------------------------------- ----------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------
  Tetrodotoxin                     Bacteria including *Vibrio* sp.                             \- Voltage-gated sodium channels;\                                                                                               \[[@b14-marinedrugs-07-00539],[@b96-marinedrugs-07-00539],[@b200-marinedrugs-07-00539]\]
                                                                                               - Inhibition of fertilisation current in *C. intestinalis;* teratogenic effect                                                   

  Maitotoxin                       Dinoflagellate *Gambierdiscus toxicus*                      \- Cationic channel\                                                                                                             \[[@b101-marinedrugs-07-00539],[@b103-marinedrugs-07-00539]\]
                                                                                               - Mouse acrosome reaction; inhibition of sea urchin egg fertilisation                                                            

  Okadaic acid                     Dinoflagellates *Prorocentrum lima* and *Dinophysis* spp.   \- Protein phosphatases;\                                                                                                        \[[@b104-marinedrugs-07-00539],[@b123-marinedrugs-07-00539]\]
                                                                                               - Inhibition of phosphorylation based processes of cellular signaling                                                            

  Brevetoxin                       Dinoflagellate *Karenia brevis*                             \- Voltage-gated sodium channels;\                                                                                               \[[@b124-marinedrugs-07-00539]\]
                                                                                               - Teratogenic effect                                                                                                             

  2-*trans*,4-*trans* Decadienal   Diatoms                                                     \- Fertilisation current;\                                                                                                       \[[@b140-marinedrugs-07-00539],[@b142-marinedrugs-07-00539]\]
                                                                                               - Inhibition of embryonic development and fertilisation in broadcast spawning marine invertebrates                               

  Domoic acid                      Alga *Chondria armata*\                                     \- Ionotropic glutamate receptors;\                                                                                              \[[@b143-marinedrugs-07-00539],[@b152-marinedrugs-07-00539]\]
                                   Diatom *Pseudonitzschia*                                    - Neurotoxicity; reduction of larval growth and survival in *P. maximus* ; reproductive failure in California sea lions.         

  Caulerpenyne                     Alga *Caulerpa taxifolia*                                   \- Microtubules;\                                                                                                                \[[@b153-marinedrugs-07-00539]\]
                                                                                               - Inhibition of first cell division                                                                                              

  Stypoldione                      Alga Stypopodium zonale                                     \- Sulfhydryl groups of proteins\                                                                                                \[[@b154-marinedrugs-07-00539]\]
                                                                                               - Inhibition of cytokinesis in sea urchin embryos                                                                                

  Sulfonoglycolipid S-ACT-1        Alga *Gelidiella acerosa*                                   \- Sperm\                                                                                                                        \[[@b155-marinedrugs-07-00539]\]
                                                                                               - Stimulation of sperm motility                                                                                                  

  Crude extract                    Alga *Gracilaria corticata,*                                \- Increase of pre-implantation loss in femal rats                                                                               \[[@b156-marinedrugs-07-00539]\]

  Crude extract                    Alga *Gelidiella acerosa*                                   \- Increase of post-implantation loss in female rats                                                                             \[[@b156-marinedrugs-07-00539]\]

  Jasplakinolide                   Sponge *Jaspis johnstoni*                                   \- Actin;\                                                                                                                       \[[@b161-marinedrugs-07-00539],[@b162-marinedrugs-07-00539]\]
                                                                                               - Arrest of *in vitro* maturation                                                                                                

  Theonellapeptolide Ie            Sponge *Petrosia*                                           \- Cortical F-actin distribution;\                                                                                               \[[@b158-marinedrugs-07-00539]\]
                                                                                               - Abnormal maturation                                                                                                            

  Strongylophorine                 Sponge *Strongylophora strongylata*                         -Actin;\                                                                                                                         \[[@b160-marinedrugs-07-00539]\]
                                                                                               -Inhibition of the maturation of starfish oocytes                                                                                

  Latrunculin                      Sponge *Latrunculia magnifica*                              \- Microfilament;\                                                                                                               \[[@b163-marinedrugs-07-00539]\]
                                                                                               - Inhibition of microfilament-mediated processes during fertilisation, cleavage and early development in sea urchins and mice.   

  (−)-10-*epi*-Axiso-nitrile-3     Sponge *Geodia Exigua*                                      \- Phosphocreatine shuttle;\                                                                                                     \[[@b165-marinedrugs-07-00539]\]
                                                                                               - Sea urchin and starfish sperm immobilization                                                                                   

  Theonellapeptolide IId           Sponge *Theonella swinhoei*                                 \- Inhibition of fertilisation of the sea urchin                                                                                 \[[@b166-marinedrugs-07-00539]\]

  Jaspisin                         Sponge *Jaspis* sp.                                         \- Exoplasmic membrane fusion;\                                                                                                  \[[@b167-marinedrugs-07-00539]--[@b169-marinedrugs-07-00539]\]
                                                                                               - Block fusion between sperm acrosomal process and egg plasma membrane; block of embryo hatching                                 

  Callyspongins A and B            Sponge *Callyspongia truncata*                              \- Inhibition of sperm-egg fusion                                                                                                \[[@b170-marinedrugs-07-00539]\]

  Halenaquinol sulfate             Sponge *Xestospongia sapra*                                 \- Inhibition of sperm-egg fusion                                                                                                \[[@b171-marinedrugs-07-00539],[@b172-marinedrugs-07-00539]\]

  Calyculin A                      Sponge *Discodermia calyx*                                  \- Protein phosphatases\                                                                                                         \[[@b174-marinedrugs-07-00539]\]
                                                                                               - Modulation of phosphorylation based processes of cellular signalling                                                           

  Bonellin                         Echiura *Bonellia viridis*                                  \- Membrane proteins;\                                                                                                           \[[@b178-marinedrugs-07-00539]\]
                                                                                               - Formation of peroxydase; cytolysis of unfertilised eggs, inhibition of cleavage and of larval motility                         

  Bivittoside D                    Sea cucumber *Bohadschia vitiensis*                         \- Sperm;\                                                                                                                       \[[@b179-marinedrugs-07-00539]\]
                                                                                               - Membrane permeabilization; spermicide activity in human                                                                        

  Methoxyconidiol                  Ascidian *Aplidium aff. densum*                             \- Microtubules;\                                                                                                                \[[@b180-marinedrugs-07-00539],[@b181-marinedrugs-07-00539]\]
                                                                                               - Inhibition of cleavage                                                                                                         
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
